Maximising the value and impact of your products
We partner with pharma, biotech, healthcare professionals, and insurers to deliver life-changing therapies to patients across Europe and provides real-world data that delivers clarity for critical decision-making.
Sciensus services
Patient access
We support healthcare professionals and the pharmaceutical industry in expanding access to vital medications. Our tailored programmes prioritise patient welfare, drive brand loyalty, improve adherence, and deliver valuable real-world data – empowering over 330,000 patients across Europe every year.
- Early access programmes
- Market access and regulatory compliance
- Finding patients for rare disease medications
- Systemic anti-cancer therapy (SACT), including chemotherapy
- Aseptic compounding
- Clinical logistics
- Nurse-supported medication
Patient engagement
Empowering patients to take an active role in their health improves adherence and outcomes. Our digital health platforms, patient apps, and in-person support provide personalised engagement, ensuring patients get the most from their treatments.
- Patient support programs (PSPs)
- Adherence and persistence interventions
- Online social platform for specific rare diseases
- Enabling self-serve medication
- Genetic medicine monitoring
- Patient advocacy
- Patient education
- Virtual Wards
Patient insights
With over 70 million patient interactions captured through our digital platforms, we uncover real-world insights that inform better treatment decisions, improve adherence, and drive patient-centric care.
- Real world data through a suite of digital products
- Enriched insight for pharma companies and healthcare professionals
- Support de-centralised clinical trials and Phase IV clinical trials
- Pharmacovigilance
Our impact
0
Patients that we support to make the most of their medicine every year
0
Hospitals and clinics that we work with, and 58 more pharma clients.
0
Countries that we operate in, including customer service centres in the UK and EU.
Expertise in over 50 therapy and clinical areas
For more than 30 years we’ve developed expertise in a growing number of key therapy and clinical areas, including the ones below.
- Haemophilia
- Thalassaemia
- Cancer
- Psoriasis
- Atopic Dermatitis
- Ulcerative Colitis
- Crohn’s Disease
- Multiple Sclerosis
- Rheumatoid arthritis
- Juvenile Idiopathic Arthritis (JIA)
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Hypercholesterolaemia
- Respiratory conditions – Cystic Fibrosis, Asthma
- Human Immunodeficiency Virus
- Lysosomal Storage Disorders
- Immunoglobulin Deficiencies
- Wound Management
- Growth Hormone Deficiency
- Pulmonary Arterial Hypertension
- Intestinal Failure
- Stoma Care
Powered by insight
Stay up to date with the news, find out more about our latest developments and learn from experts across Sciensus.
News
Sciensus achieves ISO 14001 accreditation
Sciensus is delighted to announce that, after a year of hard work across multiple teams and departments, we have earned…
News
Sciensus announces appointment of Kerry Utton as it continues to strengthen its pharma capabilities
Sciensus, a leading European life sciences organisation, focused on accelerating patients’ access to lifesaving medicines, is pleased to announce that…
Events
Clinical Pharmacy Congress 2025
Sciensus will be exhibiting at the upcoming Clinical Pharmacy Congress 2025, London, connecting with industry leaders and contributing to the conversation…